Y-mAbs Therapeutics
YMAB
#8047
Rank
$0.20 B
Marketcap
$4.54
Share price
-2.58%
Change (1 day)
-68.82%
Change (1 year)

Revenue for Y-mAbs Therapeutics (YMAB)

Revenue in 2024 (TTM): $87.68 Million USD

According to Y-mAbs Therapeutics 's latest financial reports the company's current revenue (TTM ) is $87.68 Million USD. an increase over the revenue in the year 2023 that were of $84.81 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Y-mAbs Therapeutics from 2018 to 2024

Annual revenue

Year Revenue Change
2024 $87.68 M3.38%
2023 $84.81 M29.96%
2022 $65.26 M87.03%
2021 $34.89 M68.18%
2020 $20.75 M
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA